Role of endogenous endothelin on coronary reflow after cardioplegic arrest

Objective: Endothelin plays a role in the regulation of basal coronary tone. We hypothesized that low coronary reflow and reduced cardiac function after prolonged ischemia may be due to increased release of endogenous endothelin. Methods: Using an isolated perfused rat heart, we examined the effect...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:Journal of thoracic and cardiovascular surgery 2001-12, Vol.122 (6), p.1167-1173
Hauptverfasser: Goodwin, Andrew T., Smolenski, Ryszard T., Gray, Caroline C., Jayakumar, Jay, Amrani, Mohamed, Yacoub, Magdi H.
Format: Artikel
Sprache:eng
Schlagworte:
Online-Zugang:Volltext
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
container_end_page 1173
container_issue 6
container_start_page 1167
container_title Journal of thoracic and cardiovascular surgery
container_volume 122
creator Goodwin, Andrew T.
Smolenski, Ryszard T.
Gray, Caroline C.
Jayakumar, Jay
Amrani, Mohamed
Yacoub, Magdi H.
description Objective: Endothelin plays a role in the regulation of basal coronary tone. We hypothesized that low coronary reflow and reduced cardiac function after prolonged ischemia may be due to increased release of endogenous endothelin. Methods: Using an isolated perfused rat heart, we examined the effect of the addition of various endothelin antagonists during reperfusion after 4 hours of cardioplegic arrest at 4°C. Hearts were freeze-clamped at the end of reperfusion for analysis of high-energy phosphate levels. Results are expressed as the percentages of preischemic values. Results: The addition of bosentan or Ro61-0612 (nonselective endothelin antagonists) resulted in a significant increase in the recovery of coronary flow after 30 minutes of reperfusion (100.9% vs 85.3% [P =.03] and 122.4% vs 83.7% [P
doi_str_mv 10.1067/mtc.2001.115427
format Article
fullrecord <record><control><sourceid>proquest_cross</sourceid><recordid>TN_cdi_proquest_miscellaneous_72309573</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><els_id>S0022522301716935</els_id><sourcerecordid>72309573</sourcerecordid><originalsourceid>FETCH-LOGICAL-c447t-96e84322ac074cd0c78f43ed3fafc49433143567ee3c4d50300bb444932a98183</originalsourceid><addsrcrecordid>eNp1kE1v1DAQhi0EotvCmRvKBdRLtuOPxPERVbSAKiFVIHGzvJPJrisnXuwsFf--XrJST5zswzPvvPMw9o7DmkOrr8YZ1wKArzlvlNAv2IqD0XXbNb9eshWAEHUjhDxj5zk_AIAGbl6zM861aDsjVuzbfQxUxaGiqY9bmuIh__vOOwp-quJUYUxxculvlWgI8bFyw0ypQpd6H_eBth4rlxLl-Q17NbiQ6e3pvWA_bz7_uP5S332__Xr96a5GpfRcm5Y6JYVwCFphD6i7QUnq5eAGVEZJyZVsWk0kUfUNSIDNRillpHCm4528YB-X3H2Kvw9lsR19RgrBTVTqWy0kmEbLAl4tIKaYc6lv98mP5RTLwR712aLPHvXZRV-ZeH-KPmxG6p_5k68CfDgBLqMLQ3IT-vzMSdlJAU3hLhdu57e7R5_I5tGFUGK5fZgxcyFsW2Lb406zoFSc_fGUbEZPE1JfxnC2ffT_7fsEqruYqA</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>72309573</pqid></control><display><type>article</type><title>Role of endogenous endothelin on coronary reflow after cardioplegic arrest</title><source>MEDLINE</source><source>Elsevier ScienceDirect Journals</source><source>Elektronische Zeitschriftenbibliothek - Frei zugängliche E-Journals</source><creator>Goodwin, Andrew T. ; Smolenski, Ryszard T. ; Gray, Caroline C. ; Jayakumar, Jay ; Amrani, Mohamed ; Yacoub, Magdi H.</creator><creatorcontrib>Goodwin, Andrew T. ; Smolenski, Ryszard T. ; Gray, Caroline C. ; Jayakumar, Jay ; Amrani, Mohamed ; Yacoub, Magdi H.</creatorcontrib><description>Objective: Endothelin plays a role in the regulation of basal coronary tone. We hypothesized that low coronary reflow and reduced cardiac function after prolonged ischemia may be due to increased release of endogenous endothelin. Methods: Using an isolated perfused rat heart, we examined the effect of the addition of various endothelin antagonists during reperfusion after 4 hours of cardioplegic arrest at 4°C. Hearts were freeze-clamped at the end of reperfusion for analysis of high-energy phosphate levels. Results are expressed as the percentages of preischemic values. Results: The addition of bosentan or Ro61-0612 (nonselective endothelin antagonists) resulted in a significant increase in the recovery of coronary flow after 30 minutes of reperfusion (100.9% vs 85.3% [P =.03] and 122.4% vs 83.7% [P &lt;.001], respectively, versus controls). The addition of PD155080 (endothelin A antagonist) had a similar effect (129.5% vs 91.4%, P =.008). BQ788 (endothelin B antagonist) and phosphoramidon (endothelin-converting enzyme inhibitor) had no effect. Myocardial adenosine triphosphate levels were significantly (12.1%) higher after reperfusion with Ro61-0612 (18.1 ± 0.4 μmol/g vs 16.2 ± 0.5 μmol/g, P =.01). There was no difference in the recovery of cardiac mechanical function with any of the antagonists studied. Conclusion: These results suggest that endogenous endothelin plays a role in low coronary reflow after prolonged cardioplegic arrest but does not impair recovery of myocardial function.</description><identifier>ISSN: 0022-5223</identifier><identifier>EISSN: 1097-685X</identifier><identifier>DOI: 10.1067/mtc.2001.115427</identifier><identifier>PMID: 11726892</identifier><identifier>CODEN: JTCSAQ</identifier><language>eng</language><publisher>Philadelphia, PA: Elsevier Inc</publisher><subject>Anesthesia ; Anesthesia depending on type of surgery ; Anesthesia. Intensive care medicine. Transfusions. Cell therapy and gene therapy ; Animals ; Biological and medical sciences ; Chromatography, High Pressure Liquid ; Coronary Circulation - physiology ; Dioxoles - pharmacology ; Endothelin Receptor Antagonists ; Endothelins - antagonists &amp; inhibitors ; Endothelins - physiology ; Heart Arrest, Induced ; Male ; Medical sciences ; Myocardial Reperfusion Injury - physiopathology ; Perfusion ; Pyridines - pharmacology ; Rats ; Rats, Sprague-Dawley ; Sulfonamides - pharmacology ; Tetrazoles - pharmacology ; Thoracic and cardiovascular surgery. Cardiopulmonary bypass</subject><ispartof>Journal of thoracic and cardiovascular surgery, 2001-12, Vol.122 (6), p.1167-1173</ispartof><rights>2001 American Association for Thoracic Surgery</rights><rights>2002 INIST-CNRS</rights><lds50>peer_reviewed</lds50><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c447t-96e84322ac074cd0c78f43ed3fafc49433143567ee3c4d50300bb444932a98183</citedby><cites>FETCH-LOGICAL-c447t-96e84322ac074cd0c78f43ed3fafc49433143567ee3c4d50300bb444932a98183</cites></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktohtml>$$Uhttps://www.sciencedirect.com/science/article/pii/S0022522301716935$$EHTML$$P50$$Gelsevier$$Hfree_for_read</linktohtml><link.rule.ids>309,310,314,776,780,785,786,3537,23909,23910,25118,27901,27902,65306</link.rule.ids><backlink>$$Uhttp://pascal-francis.inist.fr/vibad/index.php?action=getRecordDetail&amp;idt=13383205$$DView record in Pascal Francis$$Hfree_for_read</backlink><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/11726892$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Goodwin, Andrew T.</creatorcontrib><creatorcontrib>Smolenski, Ryszard T.</creatorcontrib><creatorcontrib>Gray, Caroline C.</creatorcontrib><creatorcontrib>Jayakumar, Jay</creatorcontrib><creatorcontrib>Amrani, Mohamed</creatorcontrib><creatorcontrib>Yacoub, Magdi H.</creatorcontrib><title>Role of endogenous endothelin on coronary reflow after cardioplegic arrest</title><title>Journal of thoracic and cardiovascular surgery</title><addtitle>J Thorac Cardiovasc Surg</addtitle><description>Objective: Endothelin plays a role in the regulation of basal coronary tone. We hypothesized that low coronary reflow and reduced cardiac function after prolonged ischemia may be due to increased release of endogenous endothelin. Methods: Using an isolated perfused rat heart, we examined the effect of the addition of various endothelin antagonists during reperfusion after 4 hours of cardioplegic arrest at 4°C. Hearts were freeze-clamped at the end of reperfusion for analysis of high-energy phosphate levels. Results are expressed as the percentages of preischemic values. Results: The addition of bosentan or Ro61-0612 (nonselective endothelin antagonists) resulted in a significant increase in the recovery of coronary flow after 30 minutes of reperfusion (100.9% vs 85.3% [P =.03] and 122.4% vs 83.7% [P &lt;.001], respectively, versus controls). The addition of PD155080 (endothelin A antagonist) had a similar effect (129.5% vs 91.4%, P =.008). BQ788 (endothelin B antagonist) and phosphoramidon (endothelin-converting enzyme inhibitor) had no effect. Myocardial adenosine triphosphate levels were significantly (12.1%) higher after reperfusion with Ro61-0612 (18.1 ± 0.4 μmol/g vs 16.2 ± 0.5 μmol/g, P =.01). There was no difference in the recovery of cardiac mechanical function with any of the antagonists studied. Conclusion: These results suggest that endogenous endothelin plays a role in low coronary reflow after prolonged cardioplegic arrest but does not impair recovery of myocardial function.</description><subject>Anesthesia</subject><subject>Anesthesia depending on type of surgery</subject><subject>Anesthesia. Intensive care medicine. Transfusions. Cell therapy and gene therapy</subject><subject>Animals</subject><subject>Biological and medical sciences</subject><subject>Chromatography, High Pressure Liquid</subject><subject>Coronary Circulation - physiology</subject><subject>Dioxoles - pharmacology</subject><subject>Endothelin Receptor Antagonists</subject><subject>Endothelins - antagonists &amp; inhibitors</subject><subject>Endothelins - physiology</subject><subject>Heart Arrest, Induced</subject><subject>Male</subject><subject>Medical sciences</subject><subject>Myocardial Reperfusion Injury - physiopathology</subject><subject>Perfusion</subject><subject>Pyridines - pharmacology</subject><subject>Rats</subject><subject>Rats, Sprague-Dawley</subject><subject>Sulfonamides - pharmacology</subject><subject>Tetrazoles - pharmacology</subject><subject>Thoracic and cardiovascular surgery. Cardiopulmonary bypass</subject><issn>0022-5223</issn><issn>1097-685X</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2001</creationdate><recordtype>article</recordtype><sourceid>EIF</sourceid><recordid>eNp1kE1v1DAQhi0EotvCmRvKBdRLtuOPxPERVbSAKiFVIHGzvJPJrisnXuwsFf--XrJST5zswzPvvPMw9o7DmkOrr8YZ1wKArzlvlNAv2IqD0XXbNb9eshWAEHUjhDxj5zk_AIAGbl6zM861aDsjVuzbfQxUxaGiqY9bmuIh__vOOwp-quJUYUxxculvlWgI8bFyw0ypQpd6H_eBth4rlxLl-Q17NbiQ6e3pvWA_bz7_uP5S332__Xr96a5GpfRcm5Y6JYVwCFphD6i7QUnq5eAGVEZJyZVsWk0kUfUNSIDNRillpHCm4528YB-X3H2Kvw9lsR19RgrBTVTqWy0kmEbLAl4tIKaYc6lv98mP5RTLwR712aLPHvXZRV-ZeH-KPmxG6p_5k68CfDgBLqMLQ3IT-vzMSdlJAU3hLhdu57e7R5_I5tGFUGK5fZgxcyFsW2Lb406zoFSc_fGUbEZPE1JfxnC2ffT_7fsEqruYqA</recordid><startdate>20011201</startdate><enddate>20011201</enddate><creator>Goodwin, Andrew T.</creator><creator>Smolenski, Ryszard T.</creator><creator>Gray, Caroline C.</creator><creator>Jayakumar, Jay</creator><creator>Amrani, Mohamed</creator><creator>Yacoub, Magdi H.</creator><general>Elsevier Inc</general><general>AATS/WTSA</general><general>Elsevier</general><scope>6I.</scope><scope>AAFTH</scope><scope>IQODW</scope><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>7X8</scope></search><sort><creationdate>20011201</creationdate><title>Role of endogenous endothelin on coronary reflow after cardioplegic arrest</title><author>Goodwin, Andrew T. ; Smolenski, Ryszard T. ; Gray, Caroline C. ; Jayakumar, Jay ; Amrani, Mohamed ; Yacoub, Magdi H.</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c447t-96e84322ac074cd0c78f43ed3fafc49433143567ee3c4d50300bb444932a98183</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2001</creationdate><topic>Anesthesia</topic><topic>Anesthesia depending on type of surgery</topic><topic>Anesthesia. Intensive care medicine. Transfusions. Cell therapy and gene therapy</topic><topic>Animals</topic><topic>Biological and medical sciences</topic><topic>Chromatography, High Pressure Liquid</topic><topic>Coronary Circulation - physiology</topic><topic>Dioxoles - pharmacology</topic><topic>Endothelin Receptor Antagonists</topic><topic>Endothelins - antagonists &amp; inhibitors</topic><topic>Endothelins - physiology</topic><topic>Heart Arrest, Induced</topic><topic>Male</topic><topic>Medical sciences</topic><topic>Myocardial Reperfusion Injury - physiopathology</topic><topic>Perfusion</topic><topic>Pyridines - pharmacology</topic><topic>Rats</topic><topic>Rats, Sprague-Dawley</topic><topic>Sulfonamides - pharmacology</topic><topic>Tetrazoles - pharmacology</topic><topic>Thoracic and cardiovascular surgery. Cardiopulmonary bypass</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Goodwin, Andrew T.</creatorcontrib><creatorcontrib>Smolenski, Ryszard T.</creatorcontrib><creatorcontrib>Gray, Caroline C.</creatorcontrib><creatorcontrib>Jayakumar, Jay</creatorcontrib><creatorcontrib>Amrani, Mohamed</creatorcontrib><creatorcontrib>Yacoub, Magdi H.</creatorcontrib><collection>ScienceDirect Open Access Titles</collection><collection>Elsevier:ScienceDirect:Open Access</collection><collection>Pascal-Francis</collection><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>MEDLINE - Academic</collection><jtitle>Journal of thoracic and cardiovascular surgery</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Goodwin, Andrew T.</au><au>Smolenski, Ryszard T.</au><au>Gray, Caroline C.</au><au>Jayakumar, Jay</au><au>Amrani, Mohamed</au><au>Yacoub, Magdi H.</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Role of endogenous endothelin on coronary reflow after cardioplegic arrest</atitle><jtitle>Journal of thoracic and cardiovascular surgery</jtitle><addtitle>J Thorac Cardiovasc Surg</addtitle><date>2001-12-01</date><risdate>2001</risdate><volume>122</volume><issue>6</issue><spage>1167</spage><epage>1173</epage><pages>1167-1173</pages><issn>0022-5223</issn><eissn>1097-685X</eissn><coden>JTCSAQ</coden><abstract>Objective: Endothelin plays a role in the regulation of basal coronary tone. We hypothesized that low coronary reflow and reduced cardiac function after prolonged ischemia may be due to increased release of endogenous endothelin. Methods: Using an isolated perfused rat heart, we examined the effect of the addition of various endothelin antagonists during reperfusion after 4 hours of cardioplegic arrest at 4°C. Hearts were freeze-clamped at the end of reperfusion for analysis of high-energy phosphate levels. Results are expressed as the percentages of preischemic values. Results: The addition of bosentan or Ro61-0612 (nonselective endothelin antagonists) resulted in a significant increase in the recovery of coronary flow after 30 minutes of reperfusion (100.9% vs 85.3% [P =.03] and 122.4% vs 83.7% [P &lt;.001], respectively, versus controls). The addition of PD155080 (endothelin A antagonist) had a similar effect (129.5% vs 91.4%, P =.008). BQ788 (endothelin B antagonist) and phosphoramidon (endothelin-converting enzyme inhibitor) had no effect. Myocardial adenosine triphosphate levels were significantly (12.1%) higher after reperfusion with Ro61-0612 (18.1 ± 0.4 μmol/g vs 16.2 ± 0.5 μmol/g, P =.01). There was no difference in the recovery of cardiac mechanical function with any of the antagonists studied. Conclusion: These results suggest that endogenous endothelin plays a role in low coronary reflow after prolonged cardioplegic arrest but does not impair recovery of myocardial function.</abstract><cop>Philadelphia, PA</cop><pub>Elsevier Inc</pub><pmid>11726892</pmid><doi>10.1067/mtc.2001.115427</doi><tpages>7</tpages><oa>free_for_read</oa></addata></record>
fulltext fulltext
identifier ISSN: 0022-5223
ispartof Journal of thoracic and cardiovascular surgery, 2001-12, Vol.122 (6), p.1167-1173
issn 0022-5223
1097-685X
language eng
recordid cdi_proquest_miscellaneous_72309573
source MEDLINE; Elsevier ScienceDirect Journals; Elektronische Zeitschriftenbibliothek - Frei zugängliche E-Journals
subjects Anesthesia
Anesthesia depending on type of surgery
Anesthesia. Intensive care medicine. Transfusions. Cell therapy and gene therapy
Animals
Biological and medical sciences
Chromatography, High Pressure Liquid
Coronary Circulation - physiology
Dioxoles - pharmacology
Endothelin Receptor Antagonists
Endothelins - antagonists & inhibitors
Endothelins - physiology
Heart Arrest, Induced
Male
Medical sciences
Myocardial Reperfusion Injury - physiopathology
Perfusion
Pyridines - pharmacology
Rats
Rats, Sprague-Dawley
Sulfonamides - pharmacology
Tetrazoles - pharmacology
Thoracic and cardiovascular surgery. Cardiopulmonary bypass
title Role of endogenous endothelin on coronary reflow after cardioplegic arrest
url https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-02-02T01%3A13%3A53IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_cross&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Role%20of%20endogenous%20endothelin%20on%20coronary%20reflow%20after%20cardioplegic%20arrest&rft.jtitle=Journal%20of%20thoracic%20and%20cardiovascular%20surgery&rft.au=Goodwin,%20Andrew%20T.&rft.date=2001-12-01&rft.volume=122&rft.issue=6&rft.spage=1167&rft.epage=1173&rft.pages=1167-1173&rft.issn=0022-5223&rft.eissn=1097-685X&rft.coden=JTCSAQ&rft_id=info:doi/10.1067/mtc.2001.115427&rft_dat=%3Cproquest_cross%3E72309573%3C/proquest_cross%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_pqid=72309573&rft_id=info:pmid/11726892&rft_els_id=S0022522301716935&rfr_iscdi=true